The p50-p50 NF-κB complex as a stimulus-specific repressor of gene activation

Molecular and Cellular Biochemistry

Volumn 265, Issue 1-2, 2004, Pages 171-183

  Tong, Xin ^a   Yin, Lei ^a,b   Washington, Raymond ^a   Rosenberg, Daniel W ^a,c   Giardina, Charles ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Colon cancer cells; Colon epithelial cells; IL 1 ; NF B; p50; TNF ; Transcription repression

Indexed keywords

AZOXYMETHANE; CARCINOGEN; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; PROTEIN P50; TUMOR NECROSIS FACTOR ALPHA; DNA; INTERLEUKIN 1; LUCIFERASE; NFKB1 PROTEIN, HUMAN; NFKB1 PROTEIN, MOUSE; RIBONUCLEASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA;

ADENOVIRUS; ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DIETARY FIBER; DNA BINDING; FEMALE; GENE ACTIVATION; GENE CONTROL; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; WHEAT BRAN; ANIMAL; ANIMAL FOOD; CELL LINE; CELL STRAIN CACO 2; CHEMISTRY; COLON; COLON TUMOR; CONFOCAL MICROSCOPY; EPITHELIUM CELL; GENETIC TRANSCRIPTION; GENETICS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTESTINE; KINETICS; LACTOSE OPERON; METABOLISM; PHYSIOLOGY; PLASMID; PROTEIN BINDING; TIME;

ADENOVIRIDAE; ANIMALIA; TRITICUM AESTIVUM;

ADENOVIRIDAE; ANIMAL FEED; ANIMALS; CACO-2 CELLS; CELL LINE; COLON; COLONIC NEOPLASMS; DIETARY FIBER; DNA; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; INTESTINES; KINETICS; LAC OPERON; LUCIFERASES; MICE; MICROSCOPY, CONFOCAL; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PLASMIDS; PROTEIN BINDING; RIBONUCLEASES; TIME FACTORS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 16644390869     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000044394.66951.4d     Document Type: Article

References (64)

1. Schottelius AJ, Baldwin AS, Jr: A role for transcription factor NF-kappa B in intestinal inflammation. Int J Colorectal Dis 14: 18-28, 1999
2. Mayo MW, Baldwin AS: The transcription factor NF-kappaB: Control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta 1470: M55-M62, 2000
3. Yamamoto Y, Gaynor RB: Role of the NF-kappaB pathway in the pathogenesis of human disease states. Curr Mol Med 1: 287-296, 2001
4. Li Q, Verma IM: NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734, 2002
5. Ghosh S, May MJ, Kopp EB: NF-kappaB and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260, 1998
6. Karin M, Ben-Neriah Y: Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity. Annu Rev Immunol 18: 621-663, 2000
7. Malek S, Huxford T, Ghosh G: Ikappa Balpha functions through direct contacts with the nuclear localization signals and the DNA binding sequences of NF-kappaB. J Biol Chem 273: 25427-25435, 1998
8. Latimer M, Ernst MK, Dunn LL, Drutskaya M, Rice NR: The N-terminal domain of IkappaB alpha masks the nuclear localization signal(s) of p50 and c-Rel homodimers. Mol Cell Biol 18: 2640-2649, 1998
9. Hoffmann A, Levchenko A, Scott ML, Baltimore D: The IkappaB-NF-kappaB signaling module: Temporal control and selective gene activation. Science 298: 1241-1245, 2002
10. Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh S: I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappaB. Cell 80: 573-582, 1995
11. Johnson DR, Douglas I, Jahnke A, Ghosh S, Pober JS: A sustained reduction in IkappaB-beta may contribute to persistent NF-kappaB activation in human endothelial cells. J Biol Chem 271: 16317-16322, 1996
12. Lin L, DeMartino GN, Greene WC: Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome. Cell 92: 819-828, 1998
13. Heusch M, Lin L, Geleziunas R, Greene WC: The generation of nfkb2 p52: Mechanism and efficiency. Oncogene 18: 6201-6208, 1999
14. Kunsch C, Ruben SM, Rosen CA: Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation. Mol Cell Biol 12: 4412-4421, 1992
15. Fujita T, Nolan GP, Ghosh S, Baltimore D: Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. Genes Dev 6: 775-787, 1992
16. Baer M, Dillner A, Schwartz RC, Sedon C, Nedospasov S, Johnson PF: Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-kappaB p50. Mol Cell Biol 18: 5678-5689, 1998
17. Zhong H, May MJ, Jimi E, Ghosh S: The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC1. Mol Cell 9: 625-636, 2002
18. Nakamura Y, Grumont RJ, Gerondakis S: NF-kappaB1 can inhibit vAbl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression. Mol Cell Biol 22: 5563-5574, 2002
19. Ziegler-Heitbrock HW, Wedel A, Schraut W, Strobel M, Wendelgass P, Sternsdorf T, Bauerle PA, Haas JG, Riethmuller G: Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. J Biol Chem 269: 17001-17004, 1994
20. Kastenbauer S, Ziegler-Heitbrock HW: NF-kappaB1 (p50) is upregulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression. Infect Immun 67: 1553-1559, 1999
21. Bohuslav J, Kravchenko VV, Parry GC, Erlich JH, Gerondakis S, Mackman N, Ulevitch RJ: Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. J Clin Invest 102: 1645-1652, 1998
22. Sha WC, Liou HC, Tuomanen EI, Baltimore D: Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80: 321-330, 1995
23. Ganchi PA, Sun SC, Greene WC, Ballard DW: A novel NF-kappa B complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerization. Mol Cell Biol 13: 7826-7835, 1993
24. Zhang W, Kone BC: NF-kappaB inhibits transcription of the H(+)-K(+)-ATPase alpha(2)-subunit gene: role of histone deacetylases. Am J Physiol Renal Physiol 283: F904-F911, 2002
25. Jobin C, Sartor RB: The I kappa B/NF-kappa B system: A key determinant of mucosalinflammation and protection. Am J Physiol Cell Physiol 278: C451-C462, 2000
26. Jobin C, Haskill S, Mayer L, Panja A, Sartor RB: Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells. J Immunol 158: 226-234, 1997
27. Wu GD, Huang N, Wen X, Keilbaugh SA, Yang H: High-level expression of I kappa B-beta in the surface epithelium of the colon: In vitro evidence for an immunomodulatory role. J Leukoc Biol 66: 1049-1056, 1999
28. Inan MS, Place R, Tolmacheva V, Wang QS, Hubbard AK, Rosenberg DW, Giardina C: IkappaBbeta-related proteins in normal and transformed colonic epithelial cells. Mol Carcinog 29: 25-36, 2000
29. Inan MS, Tolmacheva V, Wang QS, Rosenberg DW, Giardina C: Transcription factor NF-kappaB participates in regulation of epithelial cell turnover in the colon. Am J Physiol Gastrointest Liver Physiol 279: G1282-G1291, 2000
30. Yin L, Laevsky G, Giardina C: Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. J Biol Chem 276: 44641-44646, 2001
31. Segain JP, Raingeard de la Bletiere D, Bourreille A, Leray V, Gervois N, Resales C, Ferner L, Bonnet C, Blottiere HM, Galmiche JP: Butyrate inhibits inflammatory responses through NFkappaB inhibition: Implications for Crohn's disease. Gut 47: 397-403, 2000
32. Chakravortty D, Koide N, Kato Y, Sugiyama T, Mu MM, Yoshida T, Yokochi T: The inhibitory action of butyrate on lipopolysaccharide-induced nitric oxide production in RAW 264.7 murine macrophage cells. J Endotoxin Res 6: 243-247, 2000
33. Luhrs H, Gerke T, Schauber J, Dusel G, Melcher R, Scheppach W, Menzel T: Cytokine-activated degradation of inhibitory kappaB protein alpha is inhibited by the short-chain fatty acid butyrate. Int J Colorectal Dis 16: 195-201, 2001
34. Inan MS, Rasoulpour RJ, Yin L, Hubbard AK, Rosenberg DW, Giardina C: The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology 118: 724-734, 2000
35. Erdman S, Fox JG, Dangler CA, Feldman D, Horwitz BH: Typhlocolitis in NF-kappa B-deficient mice. J Immunol 166: 1443-1447, 2001
36. Place RF, Haspeslagh D, Giardina C: Induced stabilization of Ikappa-Balpha can facilitate its re-synthesis and prevent sequential degradation. J Cell Physiol 195: 470-478, 2003
37. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B: A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95: 2509-2514, 1998
38. Yao J, Mackman N, Edgington TS, Fan ST: Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem 272: 17795-17801, 1997
39. Dunn SM, Coles LS, Lang RK, Gerondakis S, Vadas MA, Shannon MF: Requirement for nuclear factor (NF)-kappa B p65 and NF-interleukin-6 binding elements in the tumor necrosis factor response region of the granulocyte colony-stimulating factor promoter. Blood 83: 2469-2479, 1994
40. Kunsch C, Rosen CA: NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Mol Cell Biol 13: 6137-6146, 1993
41. Stein B, Baldwin AS, Jr: Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B. Mol Cell Biol 13: 7191-7198, 1993
42. Newton R, Stevens DA, Hart LA, Lindsay M, Adcock IM, Barnes PJ: Superinduction of COX-2 mRNA by cycloheximide and interleukin-1beta involves increased transcription and correlates with increased NF-kappaB and JNK activation. FEBS Lett 418: 135-138, 1997
43. Yamamoto K, Arakawa T, Taketani Y, Takahashi Y, Hayashi Y, Ueda N, Yamamoto S, Kumegawa M: TNF alpha-dependent induction of cyclooxygenase-2 mediated by NF kappa B and NF-IL6. Adv Exp Med Biol 407: 185-189, 1997
44. Trede NS, Tsytsykova AV, Chatila T, Goldfeld AE, Geha RS: Transcriptional activation of the human TNF-alpha promoter by superantigen in human monocytic cells: Role of NF-kappaB. J Immunol 155: 902-908, 1995
45. Newton R, Kuitert LM, Bergmann M, Adcock IM, Barnes PJ: Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem Biophys Res Commun 237: 28-32, 1997
46. Jacobs LR, White FA: Modulation of mucosal cell proliferation in the intestine of rats fed a wheat bran diet. Am J Clin Nutr 37: 945-953, 1983
47. Jacobs LR, Schneeman BO: Effects of dietary wheat bran on rat colonic structure and mucosal cell growth. J Nutr 111: 798-803, 1981
48. Ijiri K: Apoptosis (cell death) induced in mouse bowel by 1,2-dimethylhydrazine, methylazoxymethanol acetate, and gamma-rays. Cancer Res 49: 6342-6346, 1989
49. Li YQ, Fan CY, O'Connor PJ, Winton DJ, Potten CS: Target cells for the cytotoxic effects of carcinogens in the murine small bowel. Carcinogenesis 13: 361-368, 1992
50. Potten CS, Li YQ, O'Connor PJ, Winton DJ: A possible explanation for the differential cancer incidence in the intestine, based on distribution of the cytotoxic effects of carcinogens in the murine large bowel. Carcinogenesis 13: 2305-2312, 1992
51. Papanikolaou A, Wang QS, Delker DA, Rosenberg DW: Azoxymethane-induced colon tumors and aberrant crypt foci in mice of different genetic susceptibility. Cancer Lett 130: 29-34, 1998
52. Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS Jr: NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19: 5785-5799, 1999
53. Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M: NF-kappaB function in growth control: Regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol 19: 2690-2698, 1999
54. Duyao MP, Buckler AJ, Sonenshein GE: Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter. Proc Natl Acad Sci USA 87: 4727-4731, 1990
55. Madrid LV, Mayo MW, Reuther JY, Baldwin AS, Jr: Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 276: 18934-18940, 2001
56. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W: IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274: 30353-30356, 1999
57. De Plaen IG, Qu XW, Wang H, Tan XD, Wang L, Man XB, Rozenfeld RA, Hsueh W: Endotoxin, but not platelet-activating factor, activates nuclear factor-kappaB and increases IkappaBalpha and IkappaBbeta turnover in enterocytes. Immunology 106: 577-583, 2002
58. Wang H, Qu X, De Plaen IG, Hsueh W: Platelet-activating factor and endotoxin activate CCAAT/enhancer binding protein in rat small intestine. Br J Pharmacol 133: 713-721, 2001
59. De Plaen IG, Tan XD, Chang H, Wang L, Remick DG, Hsueh W: Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet-activating factor and tumour necrosis factor. Br J Pharmacol 129: 307-314, 2000
60. De Plaen IG, Tan XD, Chang H, Qu XW, Liu QP, Hsueh W: Intestinal NF-kappaB is activated, mainly as p50 homodimers, by platelet-activating factor. Biochim Biophys Acta 1392: 185-192, 1998
61. Ziegler-Heitbrock L: The p50-homodimer mechanism in tolerance to LPS. J Endotoxin Res 7: 219-222, 2001
62. Ziegler-Heitbrock HW, Frankenberger M, Wedel A: Tolerance to lipopolysaccharide in human blood monocytes. Immunobiology 193: 217-223, 1995
63. Adib-Conquy M, Adrie C, Moine P, Asehnoune K, Fitting C, Pinsky MR, Dhainaut JF, Cavaillon JM: NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. Am J Respir Crit Care Med 162: 1877-1883, 2000
64. Cogswell PC, Scheinman RI, Baldwin AS, Jr: Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL. J Immunol 150: 2794-2804, 1993